Everolimus in Anaplastic Thyroid Cancer: A Case Series

Background: Anaplastic thyroid cancer (ATC) is a very aggressive disease and accounts for over 50% of thyroid-cancer related deaths. mTOR inhibition has shown anti-tumor activity in ATC. We report our experience treating patients with ATC with everolimus off-protocol. Methods: Patients with confirme...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Oncol
Glavni autori: Harris, Ethan J., Hanna, Glenn J., Chau, Nicole, Rabinowits, Guilherme, Haddad, Robert, Margalit, Danielle N., Schoenfeld, Jonathan, Tishler, Roy B., Barletta, Justine A., Nehs, Matthew, Janne, Pasi, Huang, Julian, Groden, Phillip, Kacew, Alec, Lorch, Jochen
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2019
Teme:
Oncology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6399130/
https://ncbi.nlm.nih.gov/pubmed/30863722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00106
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items